Intensive blood pressure management cost-effective in older adults

Intensive systolic blood pressure control in older adults results in fewer cardiovascular events and can be considered cost-effective, according to an economic evaluation.

Intensive systolic blood pressure control was defined as 110-130 mm Hg and standard control were defined as 130-150 mm Hg.

A Markov model and extensive sensitivity analyses were used to estimate incremental lifetime medical costs, quality-adjusted life-years (QALYs), and cost-effectiveness amongst patients aged 60 to 80 years with hypertension in China, the US, and the UK.

The incremental cost-effectiveness ratio (ICER) values were $12 362 per QALY gained, $25 417 per QALY gained, and $7004 per QALY gained in China, the US, and the UK, respectively.

In the US there was an 86.9% probability of cost-effectiveness at $50 000/QALY and 95.6% probability of cost-effectiveness $100 000/QALY, respectively.

Reference
Liao C, Toh HS, Sun L, et al. Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension. JAMA Netw Open. 2023;6(2):e230708. doi:10.1001/jamanetworkopen.2023.0708